ASCLETIS
Ascletis is a joint venture between U.S. and Chinese entrepreneurs aimed at building a global specialty therapeutics business dedicated to discovering and developing important new treatments for cancer and infectious diseases. Ascletis leverages U.S./European innovation and pharmaceutical/biotech strategic experience and China's capital efficiency with a goal of establishing in the near term a sustainable business and accelerated revenues through the in-licensing, late-stage clinical development, and commercialization of new medicines for the growing Chinese pharmaceutical marketplace. At the same time, the company is building long-term value through the discovery, demonstration of clinical proof-of-concept, and global partnering of novel therapeutics for life-threatening diseases.
ASCLETIS
Social Links:
Industry:
Health Care Medical Therapeutics
Founded:
2011-01-01
Address:
Chapel Hill, North Carolina, United States
Country:
United States
Website Url:
http://www.ascletis.com
Total Employee:
251+
Status:
Active
Contact:
1-919-328-0212
Email Addresses:
[email protected]
Total Funding:
255 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Apache Euro PHP GoDaddy DNS COVID-19
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Opsonix
Opsonix is a developer of a pathogen-extracting therapy designed to transform the treatment of bloodstream infections and sepsis.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Theraclone Sciences
Theraclone Sciences is a biotech company developing novel therapeutic antibodies for the treatment of infectious diseases and inflammation.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Tasly Pharmaceutical
Tasly Pharmaceutical investment in Series B - Ascletis
Focus Media
Focus Media investment in Series B - Ascletis
QianHai Equity Investment
QianHai Equity Investment investment in Series B - Ascletis
WTT Investment
WTT Investment investment in Series B - Ascletis
Goldman Sachs
Goldman Sachs investment in Series B - Ascletis
C-Bridge Capital
C-Bridge Capital investment in Series B - Ascletis
Goldman Sachs
Goldman Sachs investment in Venture Round - Ascletis
C-Bridge Capital
C-Bridge Capital investment in Series B - Ascletis
Tasly Pharmaceutical
Tasly Pharmaceutical investment in Series B - Ascletis
Pavillion Capital
Pavillion Capital investment in Series B - Ascletis
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-02-11 | Sagimet Biosciences | Ascletis investment in Venture Round - Sagimet Biosciences | 80 M USD |
| 2019-08-05 | Sagimet Biosciences | Ascletis investment in Series E - Sagimet Biosciences | 7 M USD |
| 2019-02-13 | Sagimet Biosciences | Ascletis investment in Series E - Sagimet Biosciences | 18 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-13 | Ascletis Announces Appointment of Mr. John P. Gargiulo, Former North America President and CEO of Daiichi Sankyo, as Chief Business Officer |
Official Site Inspections
http://www.ascletis.com Semrush global rank: 9.95 M Semrush visits lastest month: 76
- Host name: 47.75.123.183
- IP address: 47.75.123.183
- Location: Central Hong Kong
- Latitude: 22.2909
- Longitude: 114.15
- Timezone: Asia/Hong_Kong
